(Q36679610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Inhaled insulin (Exubera): Combining efficacy and convenience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Anthony H Barnett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and Vascular Disease Research

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

179-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160913%20AND%20SRC:MED&resulttype=core&format=json

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Injection-meal interval: recommendations of diabetologists and how patients handle it.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Alternative routes of insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Clinical pharmacokinetics and pharmacodynamics of inhaled insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

The impact of smoking on inhaled insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027

Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.027